Syverson Strege & Co Raises Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Syverson Strege & Co raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 31.1% during the fourth quarter, Holdings Channel.com reports. The fund owned 868 shares of the healthcare conglomerate’s stock after purchasing an additional 206 shares during the quarter. Syverson Strege & Co’s holdings in UnitedHealth Group were worth $439,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. NewSquare Capital LLC bought a new position in UnitedHealth Group in the 4th quarter worth $25,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at about $30,000. Promus Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter worth approximately $37,000. Finally, Pillar Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $40,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Trading Up 0.0 %

UnitedHealth Group stock opened at $516.94 on Tuesday. The firm has a market capitalization of $472.85 billion, a price-to-earnings ratio of 33.35, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm has a 50 day moving average of $509.71 and a 200 day moving average of $546.15. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $5.83 EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.62%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analyst Ratings Changes

UNH has been the subject of several recent research reports. Truist Financial lowered their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Piper Sandler cut their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Stephens lifted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Finally, Barclays reduced their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.